PharmaEssentia (LUX:PHECR) Beginning Cash Position: $764.6 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LUX:PHECR PharmaEssentia Corp LUX:PHECR
78 GF Score
Price $16.40
GF Value $14.11
View Full Analysis

What is PharmaEssentia Beginning Cash Position?

PharmaEssentia LUX:PHECR 78 Beginning Cash Position is $764.6 Mil as of Jun. 2026. GuruFocus rates LUX:PHECR with a GF Score™ of 78/100 and a GF Value™ of $14.11.

PharmaEssentia's Beginning Cash Position for the quarter that ended in Jun. 2026 was $764.6 Mil.

PharmaEssentia's quarterly Beginning Cash Position increased from Dec. 2025 ($688.3 Mil) to Mar. 2026 ($712.0 Mil) and increased from Mar. 2026 ($712.0 Mil) to Jun. 2026 ($764.6 Mil).

PharmaEssentia's annual Beginning Cash Position increased from Dec. 2023 ($329.7 Mil) to Dec. 2024 ($603.7 Mil) and increased from Dec. 2024 ($603.7 Mil) to Dec. 2025 ($671.4 Mil).

PharmaEssentia Beginning Cash Position Related Terms

PharmaEssentia Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for PharmaEssentia's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaEssentia Beginning Cash Position Chart

PharmaEssentia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 115.34 112.67 329.70 603.73 671.44

PharmaEssentia Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 743.83 684.33 688.34 712.05 764.57
LUX:PHECR
78GF Score
PharmaEssentia Corp LUX:PHECR
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaEssentia Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $764.6 Mil mean?
PharmaEssentia (LUX:PHECR) has a Beginning Cash Position of $764.6 Mil as of Jun. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on PharmaEssentia and its competitors.
Is PharmaEssentia's Beginning Cash Position too high?
PharmaEssentia's current Beginning Cash Position is $764.6 Mil. Overall, PharmaEssentia has a GF Score™ of 78/100, reflecting its overall financial health beyond just this single metric.
How does PharmaEssentia's Beginning Cash Position compare to ZTS?
PharmaEssentia's Beginning Cash Position of $764.6 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on PharmaEssentia and its competitors. PharmaEssentia's current Beginning Cash Position is $764.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaEssentia stock overvalued right now?
PharmaEssentia (LUX:PHECR) has a current Beginning Cash Position of $764.6 Mil. The stock's GF Value™ is $14.11, compared to a current price of $16.40 — trading 16.2% above its estimated fair value. The current Beginning Cash Position is $764.6 Mil. PharmaEssentia's overall GF Score™ is 78/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For PharmaEssentia (LUX:PHECR), the current Beginning Cash Position is $764.6 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PharmaEssentia (LUX:PHECR) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaEssentia stock appears to be overvalued. The current stock price of $16.40 is trading 16.2% above its estimated GF Value™ of $14.11.

Key valuation signals for LUX:PHECR:

  • Beginning Cash Position: $764.6 Mil
  • GF Value™: $14.11 vs. price of $16.40 (16.2% above fair value)
  • GF Score™: 78/100

No single metric tells the full story. See the LUX:PHECR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PharmaEssentia Business Description

Other Exchanges 6446:Taiwan
Address 13th Floor, No.3, Park Street, Nangang District, Taipei, TWN, 115
PharmaEssentia Corp engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API and new drug patterns developments. Its products include BESREMi, Ropeginterferon alfa-2b, Ropeg + anti PD-1, PEG-IL-2, PEG-Cytokines, PD-1-IL-2v, NY-ESO-1 TCR-T, among others. It derives revenue from medicine products sales from contracts with customers.
78GF Score

Get the complete analysis for LUX:PHECR

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.40
Price
$14.11
GF Value